Quality of Life in the Trastuzumab for Gastric Cancer Trial

BACKGROUND. The Trastuzumab for Gastric Cancer phase III trial demonstrated that combining trastuzumab with chemotherapy significantly improved overall survival compared with chemotherapy alone in HER2-positive advanced gastric or gastroesophageal junction cancer. We report health-related quality of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Satoh, Taroh, Bang, Yung-Jue, Gotovkin, Evgeny A., Hamamoto, Yasuo, Kang, Yoon-Koo, Moiseyenko, Vladimir M., Ohtsu, Atsushi, Van Cutsem, Eric, Al-Sakaff, Nedal, Urspruch, Alexa, Hill, Julie, Weber, Harald A., Chung, Hyun-Cheol
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2014
Assuntos:
Gastrointestinal Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4077451/
https://ncbi.nlm.nih.gov/pubmed/24951609
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0058
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados